Darius M Moshfeghi1. 1. Byers Eye Institute, Horngren Family Vitreoretinal Center, Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, California, USA. Electronic address: dariusm@stanford.edu.
Abstract
PURPOSE: To describe a framework for screening and treatment of retinopathy of prematurity (ROP) using telemedicine screening with laser and/or vascular endothelial growth factor inhibitor treatment strategies. DESIGN: Literature review and perspective. METHODS: Review of the literature and the author's experience. RESULTS: Undetermined. CONCLUSIONS: Telemedicine can be deployed on a national basis to provide quaternary-level screening for ROP. At-risk patients for treatment could then be directed to receive either laser photocoagulation or vascular endothelial growth factor inhibitor intravitreal injections followed at a later time by examination under anesthesia, fluorescein angiography, and diode laser photocoagulation as indicated.
PURPOSE: To describe a framework for screening and treatment of retinopathy of prematurity (ROP) using telemedicine screening with laser and/or vascular endothelial growth factor inhibitor treatment strategies. DESIGN: Literature review and perspective. METHODS: Review of the literature and the author's experience. RESULTS: Undetermined. CONCLUSIONS: Telemedicine can be deployed on a national basis to provide quaternary-level screening for ROP. At-risk patients for treatment could then be directed to receive either laser photocoagulation or vascular endothelial growth factor inhibitor intravitreal injections followed at a later time by examination under anesthesia, fluorescein angiography, and diode laser photocoagulation as indicated.
Authors: Tapan P Patel; Michael T Aaberg; Yannis M Paulus; Philip Lieu; Vaidehi S Dedania; Cynthia X Qian; Cagri G Besirli; Todd Margolis; Daniel A Fletcher; Tyson N Kim Journal: Graefes Arch Clin Exp Ophthalmol Date: 2019-09-09 Impact factor: 3.117